Compare Erasca Inc. Common Stock (ERAS) vs MaxLinear Inc. Common Stock (MXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs MaxLinear Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.62 (market cap $5.40B), while MaxLinear Inc. Common Stock trades at $96.37 (market cap $8.50B). The key difference: MaxLinear Inc. Common Stock is the larger of the two by market cap, and Erasca Inc. Common Stock is more actively traded (9,533,185 versus 4,008,439). Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and MaxLinear Inc. Common Stock for 0 Days on average.
| ERAS | MXL | |
|---|---|---|
Market Cap | $5.40B | $8.50B |
Volume | 9,533,185 | 4,008,439 |
Sector | Health | Technology |
52-Week High | $22.47 | $128.03 |
52-Week Low | $2.20 | $13.05 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.18B | $8.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About MaxLinear Inc. Common Stock
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →
